Cargando…

The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model

Jumonji domain-containing 3 (JMJD3/KDM6B) is a histone demethylase that plays an important role in regulating development, differentiation, immunity, and tumorigenesis. However, the mechanisms responsible for the epigenetic regulation of inflammation during mastitis remain incompletely understood. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing-Jing, Wang, Xia, Xian, Yin-Er, Chen, Zi-Qing, Sun, You-Peng, Fu, Yi-Wu, Wu, Zhi-Kai, Li, Pei-Xuan, Zhou, Er-Shun, Yang, Zheng-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168612/
https://www.ncbi.nlm.nih.gov/pubmed/35526564
http://dx.doi.org/10.1016/j.jbc.2022.102017
_version_ 1784721041411538944
author Wang, Jing-Jing
Wang, Xia
Xian, Yin-Er
Chen, Zi-Qing
Sun, You-Peng
Fu, Yi-Wu
Wu, Zhi-Kai
Li, Pei-Xuan
Zhou, Er-Shun
Yang, Zheng-Tao
author_facet Wang, Jing-Jing
Wang, Xia
Xian, Yin-Er
Chen, Zi-Qing
Sun, You-Peng
Fu, Yi-Wu
Wu, Zhi-Kai
Li, Pei-Xuan
Zhou, Er-Shun
Yang, Zheng-Tao
author_sort Wang, Jing-Jing
collection PubMed
description Jumonji domain-containing 3 (JMJD3/KDM6B) is a histone demethylase that plays an important role in regulating development, differentiation, immunity, and tumorigenesis. However, the mechanisms responsible for the epigenetic regulation of inflammation during mastitis remain incompletely understood. Here, we aimed to investigate the role of JMJD3 in the lipopolysaccharide (LPS)-induced mastitis model. GSK-J1, a small molecule inhibitor of JMJD3, was applied to treat LPS-induced mastitis in mice and in mouse mammary epithelial cells in vivo and in vitro. Breast tissues were then collected for histopathology and protein/gene expression examination, and mouse mammary epithelial cells were used to investigate the mechanism of regulation of the inflammatory response. We found that the JMJD3 gene and protein expression were upregulated in injured mammary glands during mastitis. Unexpectedly, we also found JMJD3 inhibition by GSK-J1 significantly alleviated the severity of inflammation in LPS-induced mastitis. These results are in agreement with the finding that GSK-J1 treatment led to the recruitment of histone 3 lysine 27 trimethylation (H3K27me3), an inhibitory chromatin mark, in vitro. Furthermore, mechanistic investigation suggested that GSK-J1 treatment directly interfered with the transcription of inflammatory-related genes by H3K27me3 modification of their promoters. Meanwhile, we also demonstrated that JMJD3 depletion or inhibition by GSK-J1 decreased the expression of toll-like receptor 4 and negated downstream NF-κB proinflammatory signaling and subsequently reduced LPS-stimulated upregulation of Tnfa, Il1b, and Il6. Together, we propose that targeting JMJD3 has therapeutic potential for the treatment of inflammatory diseases.
format Online
Article
Text
id pubmed-9168612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-91686122022-06-08 The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model Wang, Jing-Jing Wang, Xia Xian, Yin-Er Chen, Zi-Qing Sun, You-Peng Fu, Yi-Wu Wu, Zhi-Kai Li, Pei-Xuan Zhou, Er-Shun Yang, Zheng-Tao J Biol Chem Research Article Jumonji domain-containing 3 (JMJD3/KDM6B) is a histone demethylase that plays an important role in regulating development, differentiation, immunity, and tumorigenesis. However, the mechanisms responsible for the epigenetic regulation of inflammation during mastitis remain incompletely understood. Here, we aimed to investigate the role of JMJD3 in the lipopolysaccharide (LPS)-induced mastitis model. GSK-J1, a small molecule inhibitor of JMJD3, was applied to treat LPS-induced mastitis in mice and in mouse mammary epithelial cells in vivo and in vitro. Breast tissues were then collected for histopathology and protein/gene expression examination, and mouse mammary epithelial cells were used to investigate the mechanism of regulation of the inflammatory response. We found that the JMJD3 gene and protein expression were upregulated in injured mammary glands during mastitis. Unexpectedly, we also found JMJD3 inhibition by GSK-J1 significantly alleviated the severity of inflammation in LPS-induced mastitis. These results are in agreement with the finding that GSK-J1 treatment led to the recruitment of histone 3 lysine 27 trimethylation (H3K27me3), an inhibitory chromatin mark, in vitro. Furthermore, mechanistic investigation suggested that GSK-J1 treatment directly interfered with the transcription of inflammatory-related genes by H3K27me3 modification of their promoters. Meanwhile, we also demonstrated that JMJD3 depletion or inhibition by GSK-J1 decreased the expression of toll-like receptor 4 and negated downstream NF-κB proinflammatory signaling and subsequently reduced LPS-stimulated upregulation of Tnfa, Il1b, and Il6. Together, we propose that targeting JMJD3 has therapeutic potential for the treatment of inflammatory diseases. American Society for Biochemistry and Molecular Biology 2022-05-06 /pmc/articles/PMC9168612/ /pubmed/35526564 http://dx.doi.org/10.1016/j.jbc.2022.102017 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Wang, Jing-Jing
Wang, Xia
Xian, Yin-Er
Chen, Zi-Qing
Sun, You-Peng
Fu, Yi-Wu
Wu, Zhi-Kai
Li, Pei-Xuan
Zhou, Er-Shun
Yang, Zheng-Tao
The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title_full The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title_fullStr The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title_full_unstemmed The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title_short The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
title_sort jmjd3 histone demethylase inhibitor gsk-j1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168612/
https://www.ncbi.nlm.nih.gov/pubmed/35526564
http://dx.doi.org/10.1016/j.jbc.2022.102017
work_keys_str_mv AT wangjingjing thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT wangxia thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT xianyiner thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT chenziqing thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT sunyoupeng thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT fuyiwu thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT wuzhikai thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT lipeixuan thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT zhouershun thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT yangzhengtao thejmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT wangjingjing jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT wangxia jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT xianyiner jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT chenziqing jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT sunyoupeng jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT fuyiwu jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT wuzhikai jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT lipeixuan jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT zhouershun jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel
AT yangzhengtao jmjd3histonedemethylaseinhibitorgskj1ameliorateslipopolysaccharideinducedinflammationinamastitismodel